Freestone Grove Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.5M Buy
226,560
+28,070
+14% +$7.05M 0.34% 99
2025
Q4
$56.4M Buy
198,490
+139,434
+236% +$43.6M 0.41% 63
2025
Q3
$18.2M Sell
59,056
-90,279
-60% -$28.3M 0.14% 227
2025
Q2
$46.9M Buy
149,335
+40,755
+38% +$11.8M 0.35% 103
2025
Q1
$28.5M Buy
108,580
+106,986
+6,712% +$29M 0.29% 129
2024
Q4
$416K Buy
+1,594
New +$401K 0.01% 408

Other funds holding PODD

Freestone Grove Partners's PODD Position: Q1 2026 in Review

Freestone Grove Partners increased its Insulet (PODD) stake by 14% in Q1 2026, buying an estimated $7.05M and bringing the position to 226,560 shares worth $47.5M. The position accounts for 0.34% of the portfolio, ranked #99.

Freestone Grove Partners first reported a position in PODD in Q4 2024 and has held it in 6 quarters since. The position peaked at $56.4M in Q4 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Freestone Grove Partners held 226,560 shares of Insulet worth $47.5M as of Q1 2026.
  • Freestone Grove Partners bought 28,070 Insulet shares in Q1 2026, an estimated $7.05M.
  • Insulet made up 0.34% of Freestone Grove Partners's portfolio in Q1 2026, its #99 holding.
  • Freestone Grove Partners first reported a position in Insulet in Q4 2024 and has held it in 6 quarters since.
  • Freestone Grove Partners's Insulet position peaked at $56.4M in Q4 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.